Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01016899 · ClinicalTrials.gov registry record

Electronic Brachytherapy for the Treatment of NMSC

A clinical trial of Squamous Cell Carcinoma and Basal Cell Carcinoma, sponsored by Xoft.

Completed
Registry status
187
Enrollment target
5
Study locations

NCT01016899 is a study of Squamous Cell Carcinoma and Basal Cell Carcinoma that has completed, run by Xoft. The registered enrollment target is 187 participants, above the 100-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (87% higher). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01016899, a study of Squamous Cell Carcinoma and Basal Cell Carcinoma, has completed, sponsored by Xoft.

COMPLETED
Registry status
187 participants
Enrollment target
5
Study locations

Study Summary

The objective of this study is to record recurrence in patients treated for nonmelanoma (basal cell and squamous cell carcinomas) skin cancer using the Xoft Axxent Electronic Brachytherapy System. Additional objectives include evaluate the appearance of the treated area in patients treated for nonmelanoma skin cancer using the Xoft Axxent Electronic Brachytherapy System and record the occurrence of radiation therapy related skin changes in patients treated for nonmelanoma skin cancer.

Conditions Studied

Squamous Cell Carcinoma Basal Cell Carcinoma

Interventions

  • RADIATION electronic brachytherapy

Study Locations (5)

Arizona

  • Cancer Treatment Services - AZ - Casa Grande
  • Southwest Oncology Centers - Scottsdale

Alabama

  • DCH Cancer Center - Tuscaloosa

California

  • Diablo Valley Oncology and Hematology Medical Group - Pleasant Hill

Tennessee

  • Parkridge Medical Center - Sara Cannon Cancer Center - Chattanooga

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2009-08
Est. Completion 2013-08

Sponsor

Xoft

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01016899

The ClinicalTrials.gov registry entry for NCT01016899 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 100-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (87% higher). The listed sponsor is Xoft, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Squamous Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which electronic brachytherapy is the first listed.

NCT01016899 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Alabama, California.

Frequently Asked Questions

What is clinical trial NCT01016899 about?

NCT01016899 is a clinical study titled "Electronic Brachytherapy for the Treatment of NMSC". The objective of this study is to record recurrence in patients treated for nonmelanoma (basal cell and squamous cell carcinomas) skin cancer using the Xoft Axxent Electronic Brachytherapy System. Additional objectives include evaluate the appearance of the treated area in patients treated for nonme...

What is the current status of trial NCT01016899?

This trial is currently completed. The enrollment target is 187 participants. The study started on 2009-08. Estimated completion is 2013-08.

What conditions does trial NCT01016899 study?

This clinical trial studies the following conditions: Squamous Cell Carcinoma, Basal Cell Carcinoma.

What interventions are being tested in trial NCT01016899?

The interventions under investigation include: electronic brachytherapy (RADIATION).

Who is sponsoring clinical trial NCT01016899?

This trial is sponsored by Xoft, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01016899 being conducted?

This trial has 5 study locations across Alabama, Arizona, California, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Squamous Cell Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Squamous Cell Carcinoma

All registered trials for this condition

Basal Cell Carcinoma

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.